A conserved role for the ALS-linked splicing factor SFPQ in repression of pathogenic cryptic last exons
SFPQ is a splicing factor and its mutations are associated to amyotrophic lateral sclerosis (ALS) patients. Here, the authors show that SFPQ represses the use of pathogenic cryptic last exons in zebrafish, mouse and human cells.
Guardado en:
Autores principales: | Patricia M. Gordon, Fursham Hamid, Eugene V. Makeyev, Corinne Houart |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dbf009023d6d49ffada9dbd438aaf6be |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
por: Andreas Neueder, et al.
Publicado: (2017) -
Hotspot exons are common targets of splicing perturbations
por: David T. Glidden, et al.
Publicado: (2021) -
Conserved protein Pir2ARS2 mediates gene repression through cryptic introns in lncRNAs
por: Gobi Thillainadesan, et al.
Publicado: (2020) -
Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS
por: Raphaelle Luisier, et al.
Publicado: (2018) -
Promoter-proximal pausing mediated by the exon junction complex regulates splicing
por: Junaid Akhtar, et al.
Publicado: (2019)